Bayer faces Swiss criminal probe over cerivastatin.
Fleck
Fiona
F
D000924:Anticholesteremic Agents / Q000009:adverse effects*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004347:Drug Interactions; D006801:Humans; D011725:Pyridines / Q000009:adverse effects*; D013557:Switzerland
D000924:Anticholesteremic Agents; D011725:Pyridines; C086276:cerivastatin